Woman Links Contraceptive Injection to Health Issues

Sarah Watson, a 30-year-old mother of two, discontinued a contraceptive injection after learning of its potential link to benign brain tumors. Shortly after, she found herself unconscious at home, requiring hospital treatment.

Initial Symptoms and Misdiagnosis

Watson experienced unusual symptoms, including headaches, dizziness, and strange sensations like a head rush, after stopping the Depo-Provera injection. Despite visiting her doctor, who initially diagnosed anxiety, she believed a different cause existed.

‘I knew deep down it wasn’t related to my mental health,’ she explained.

Watson’s symptoms persisted for weeks until a distressing incident occurred. She collapsed after getting out of bed and hit her head, leading to unconsciousness, bleeding, and shaking.

An ambulance arrived hours later. In the hospital, a CT scan revealed a concussion. Upon mentioning she stopped the contraceptive injection, a doctor suggested withdrawal symptoms could explain her condition.

Medical Insight

Dr. Julie Hammond discussed the non-recognized yet possible withdrawal symptoms from stopping Depo-Provera. Hormone levels gradually normalize, causing potential physical and emotional changes.

‘Women may experience mood and energy changes during this transition,’ Hammond stated.

Ovulation typically resumes within 15 to 49 weeks, but may take up to a year. Hormone fluctuations can result in irregular bleeding or other menstrual changes.

Watson’s Decision

Watson, formerly using the injection for over two years, decided to stop after learning of meningioma risks. Previously, she sought this method following a pregnancy with twins while on the contraceptive pill.

When first prescribed the injection, weight gain was noted as a side effect. Earlier this year, the meningioma concern prompted her immediate discontinuation.

Data from the Centers for Disease Control and Prevention (CDC) shows 24.5% of approximately 64,000 sexually active women aged 15 to 49 report using the three-month injectable contraceptive.

Update on Depo-Provera

Warnings on Depo-Provera were updated after linking prolonged medroxyprogesterone acetate use to meningioma. Pfizer’s leaflet advises seeking medical attention if experiencing specific symptoms like vision changes or headaches.

A Pfizer spokesperson assured patient safety as a priority and highlighted the drug’s longstanding efficacy. Individuals should consult healthcare professionals if concerned or facing side effects.